1. Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
   Anna Pawłowska et al, 2023, International Journal of Molecular Sciences CrossRef
2. The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives
   Md. Rezaul Islam et al, 2023, Molecules CrossRef
3. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
   Giovanna Cocomazzi et al, 2024, International Journal of Molecular Sciences CrossRef
4. CDCA3 exhibits a role in promoting the progression of ovarian cancer
   Shan Gong et al, 2022, Tissue and Cell CrossRef
5. Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer
   Jeffrey M McManus et al, 2022, JNCI Cancer Spectrum CrossRef
6. Biomarkers in Ovarian Cancer: Towards Personalized Medicine
   Carlos López-Portugués et al, 2024, Proteomes CrossRef
7. Molecular Management of High-Grade Serous Ovarian Carcinoma
   Paula Punzón-Jiménez et al, 2022, International Journal of Molecular Sciences CrossRef
8. Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
   Ji-Won Ryu et al, 2023, Frontiers in Oncology CrossRef
9. From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches
   Adel Alblihy, 2024, Frontiers in Pharmacology CrossRef
10. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
    Lara S. Lemon et al, 2022, Gynecologic Oncology CrossRef
11. Role of chemotherapeutic drugs in immunomodulation of cancer
    Oishi Mukherjee et al, 2023, Current Research in Immunology CrossRef
12. Effects of the Overexpression of Progesterone Receptors on a Precancer p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line
    Yu-Hsun Chang et al, 2023, International Journal of Molecular Sciences CrossRef
13. Study of the radioprotective properties of fumaric acid and 3-hydroxypyridine fumarate under the action of ionizing radiation on human cells
    P. S. Kuptsova et al, 2023, Radiatsionnaya Gygiena = Radiation Hygiene CrossRef
14. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review
    Suvitha Anbarasu et al, 2023, Medical Oncology CrossRef
15. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resistance CrossRef
16. Coicis Semen for the treatment of malignant tumors of the female reproductive system: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics, and pharmacodynamics
    Xue Pan et al, 2023, Frontiers in Pharmacology CrossRef
17. Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions
    Szidónia Farkas et al, 2022, Biomedicines CrossRef
18. Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells
    Hinanit Koltai et al, 2022, Cancers CrossRef
19. Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive
    Stephanie Sober et al, 2024, Contraception CrossRef
20. Hormonal Therapy in Pretreated Patients With Recurrent Ovary Granulosa Cell Tumor
    Izzet Dogan et al, 2024, Journal of Pharmacy Practice CrossRef
21. Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells
    Éva Márton et al, 2023, Toxins CrossRef